Katherine A. High
For developing a therapy for inherited retinal degeneration that became the first FDA-approved gene therapy for a genetic disease.
Affilié au moment de l'attribution du prix
Children's Hospital of Philadelphia
Philadelphia, États-Unis
Philadelphia, États-Unis
New York, États-Unis